A Commitment TO Diagnostics
Website Disclaimer
The information contained in this website is for general information purposes only. BÜHLMANN endeavours to keep the information up-to-date and correct. However, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.
In no event will we be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from loss of data or profits, arising out of or in connection with the use of this website.
Copyright Notice
This website and its content is copyright of BÜHLMANN Laboratories AG [2009]. All rights reserved.
Any redistribution or reproduction of part or all of the contents in any form is prohibited other than the following:
• you may print or download to a local hard disk extracts for your personal and non-commercial use only
• you may copy the content to individual third parties for their personal use, but only if you acknowledge the website as the source of the material
You may not, except with our express written permission, distribute or commercially exploit the content. Nor may you transmit it or store it in any other website or other form of electronic retrieval system.
Contact
Baselstr. 55
CH-4124 Schönenbuch
Switzerland
Fon: +41 61 487 12 12
Fax: +41 61 487 12 34
info@buhlmannlabs.ch
Your local distributor
Order
About us
Job opportunities
Search
News
BUHLMANN as gold sponsor of the 5th Santorini Pharmacogenetics Conference
Functional Genomics Towards Personalized Health Care The 5th Santorini Conference will take place in Thira, Greece, on September 30th , October 1st and 2 more
Measuring of Mineralwaters and Softdrinks on Arena and Aquakem
The high expectations in speed, accuracy and precision have been achieved in an evaluation study on Arena 30 at Feldschlösschen (Carlsberg Group), Rheinfe more
BÜHLMANN Calprotectin Test introduced in Belgium
The Hartziekenhuis Hospital in Belgium introduced the BÜHLMANN Calprotectin Assay for testing of faecal samples of IBD patients. A thorough evaluation pro more
Distribution of BioPorto’s NGAL ELISA
In January 2010 BÜHLMANN starts the distribution of the innovative diagnostic products of BioPorto in Switzerland , Austria and France . more
BÜHLMANN Core | BÜHLMANN Molecular | BÜHLMANN Medical | BÜHLMANN Industrial | Customer Relations | About Us |
Contact |
